United States · Venture startup

Who invested in Clarient

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$51Mraised across 2 rounds since 2009, from 2 sources

$40MVenture$11MVenture
Latest round
Venture, $11MDec 2009
Biggest round
$40MVenture · May 2009
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2010
$40MVenture$11MVenture
First round
Venture, $40M
May 2009
Biggest round
$40M
Venture · May 2009
Between rounds
7 months
from the last two

The rounds

  1. Dec 2009
    Venture$11M

    No investor was named in the report.

    From a historical funding recordSEC filing: $11M sold, first sale Dec 2009

  2. May 2009
    Venture$40M1 new

    Reported by deals.venturebeat.comSEC filing: $29M sold, first sale Mar 2009

Exits

ExitBuyerPriceWhen
AcquiredNeoGenomics Laboratories$275MOct 2015
AcquiredGE Healthcare$587MOct 2010

From historical deal records. Wrong? Tell us.

Everyone who backed them

Oak Investment PartnersPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Clarient

Who invested in Clarient?

Clarient's investors include Oak Investment Partners.

How much has Clarient raised?

Clarient has raised $51M across 2 rounds since 2009.

When did Clarient last raise?

Clarient's most recent round was a Venture of $11M in Dec 2009.

What was Clarient's biggest round?

Clarient's largest round on record is $40M (Venture), in May 2009.

Who backed Clarient first?

Clarient's first round on record, in May 2009, was backed by Oak Investment Partners.

What stage is Clarient at?

Clarient's latest named round is a Venture, in Dec 2009.

Where is Clarient based?

Clarient is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.